InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.078 0.004 (4.88%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$24 NOXCOVID Trial Advances to Final Stage 8 Mar 2021 8:56AM $0.680 $0.078 fallen by 88.53%
$24 Noxopharm Presents to H.C. Wainwright Global Conference 5 Mar 2021 9:30AM $0.695 $0.078 fallen by 88.78%
$24 Cleansing Notice 4 Mar 2021 1:24PM $0.680 $0.078 fallen by 88.53%
$24 Appendix 2A 4 Mar 2021 1:23PM $0.680 $0.078 fallen by 88.53%
$24 Noxopharm Receives A$4.59M Federal Gov R&D Tax Rebate 2 Mar 2021 9:32AM $0.735 $0.078 fallen by 89.39%
$24 Proposed issue of Securities - NOX 1 Mar 2021 9:46AM $0.685 $0.078 fallen by 88.61%
$24 Lapsing of Unlisted Options and Shortfall Shares 1 Mar 2021 9:43AM $0.685 $0.078 fallen by 88.61%
$24 Change of Director's Interest Notice - PM 1 Mar 2021 8:19AM $0.685 $0.078 fallen by 88.61%
$24 Change in substantial holding 26 Feb 2021 4:30PM $0.685 $0.078 fallen by 88.61%
$24 Change of Director's Interest Notice - GK 26 Feb 2021 4:29PM $0.685 $0.078 fallen by 88.61%
$24 Cleansing Notice 26 Feb 2021 4:26PM $0.685 $0.078 fallen by 88.61%
$24 Appendix 2A 26 Feb 2021 4:24PM $0.685 $0.078 fallen by 88.61%
$24 Company Announcement Regarding Appendix 3Y Disclosures 24 Feb 2021 9:22AM $0.730 $0.078 fallen by 89.32%
$24 Change in substantial holding 24 Feb 2021 9:19AM $0.730 $0.078 fallen by 89.32%
$24 Change of Director's Interest Notice - GK 24 Feb 2021 9:18AM $0.730 $0.078 fallen by 89.32%
$24 Noxopharm Updated Corporate Presentation February-March 2021 23 Feb 2021 9:22AM $0.760 $0.078 fallen by 89.74%
$24 Option Underwriting Agreement to Secure Funds 19 Feb 2021 5:09PM $0.790 $0.078 fallen by 90.13%
$24 Cleansing Notice 19 Feb 2021 3:38PM $0.790 $0.078 fallen by 90.13%
$24 Appendix 2A 19 Feb 2021 3:37PM $0.790 $0.078 fallen by 90.13%
$24 Noxopharm CEO Letter to Shareholders February 2021 16 Feb 2021 9:51AM $0.940 $0.078 fallen by 91.70%
$24 Appendix 4D and Half Year Financial Report 16 Feb 2021 9:47AM $0.940 $0.078 fallen by 91.70%
$24 Cleansing Notice 15 Feb 2021 2:44PM $0.935 $0.078 fallen by 91.66%
$24 Appendix 2A 15 Feb 2021 2:43PM $0.935 $0.078 fallen by 91.66%
$24 LuPIN Survival Outcome Confirmed by Conference Presentation 15 Feb 2021 9:12AM $0.920 $0.078 fallen by 91.52%
$24 Major Survival Benefit in Prostate Cancer Patients Announced 9 Feb 2021 9:16AM $0.685 $0.078 fallen by 88.61%

276 - 300 of 794 results

Page 12 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.